retatrutide side effects trial results New Phase 3 data just dropped 👀 Eli Lilly's reported average weight loss approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats I personally know plenty of

There is also the brain delivery angle

Because participants were enrolled while blinding was active, quotas could not be applied to ensure an even distribution of participants across treatment allocations

One recent randomized control trial split participants into an exercise group, a GLP-1 group and a combined group

When we talk about compounded weight loss medication in the context of GLP-1 receptor agonists like semaglutide and tirzepatide, we're referring to versions of these drugs that are prepared by a licensed compounding pharmacy rather than manufactured by the brand-name pharmaceutical companies (Novo Nordisk for Ozempic/Wegovy and Eli Lilly for Mounjaro/Zepbound)

Diabetologia 63(3):473485 van Can J, Sloth B, Jensen CB, Flint A, Blaak EE, Saris WH (2014) Effects of the once-daily GLP-1 analog liraglutide on gastric emptying, glycemic parameters, appetite and energy metabolism in obese, non-diabetic adults

The timeline changes dramatically based on these factors